What is behind the EU's dispute with AstraZeneca over COVID-19 vaccines?

By Aditya Goenka, Professor of Economics, University of Birmingham

Hopes that rolling out vaccines would control the the pandemic have been dealt a blow by an emerging dispute between the EU and AstraZeneca. The manufacturer has said that because of production problems in Belgium, it will not be able to supply as many vaccines as expected to the EU, but that its supply to UK will be unaffected.

In response, the EU has said it should be given a share of AstraZeneca doses manufactured in Britain, and politicians have suggested it could control…

Read complete article

~	India’s LGBTQIA+ community notches legal wins but still faces societal hurdles to acceptance, equal rights

~	Al Ahly and Esperance highlight the dominance of North Africa in club football. Lessons for other African teams

~	Sri Lanka: Fifteen years after the end of war, victims still await justice at Mullivaikkal

~	South African communities vs Shell: high court victories show that cultural beliefs and practices count in climate cases

~	Why the New Yorker blocked UK website readers from its Lucy Letby story – an expert explains

~	How a British military march became the distinctive sound of American graduations

~	UN rights office urges Sri Lanka to reveal fate of the disappeared

~	World Should Rally to Halt Unfolding Atrocities in Darfur

~	It’s a mistake to dismiss Bridgerton as fluffy period drama

~	How newborn chicks are helping to settle a centuries-old debate about cognition and our senses